RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: bipolar disorder
Accession: DOID:3312
browse the term
Definition: A mood disorder that involves alternating periods of mania and depression. (DO)
Synonyms: exact_synonym: BPAD; Mania; bipolar affective disorder; bipolar affective psychoses; bipolar affective psychosis; bipolar and related disorders; bipolar depression; bipolar disorder manic phase; bipolar disorders; depressive-manic psych.; manias; manic bipolar I disorder; manic bipolar affective disorder; manic depression; manic depressive disorder; manic depressive psychosis; manic disorder; manic disorders; manic state; manic states; manic-depressive psychoses; mixed bipolar disorder
related_synonym: BIPOLAR AFFECTIVE DISORDER, SUSCEPTIBILITY TO
primary_id: MESH:D000068105 ; MESH:D001714
xref: EFO:0000289 ; GARD:10249 ; ICD10CM:F31 ; ICD9CM:296.40 ; ICD9CM:296.60 ; ICD9CM:296.80 ; MONDO:0004985 ; NCI:C34423 ; NCI:C34424 ; NCI:C34805
For additional species annotation, visit the
Alliance of Genome Resources .
G
Ace
angiotensin I converting enzyme
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
G
Adcy2
adenylate cyclase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645
G
Add3
adducin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:plasma
RGD
PMID:22137759
RGD:5686381
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
G
Agt
angiotensinogen
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
G
Akap11
A-kinase anchoring protein 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35410376
NCBI chr15:60,320,839...60,365,480
Ensembl chr15:60,320,839...60,365,335
G
Akt1
AKT serine/threonine kinase 1
ISO
DNA:SNP, haplotype: :multiple (human)
RGD
PMID:20214684
RGD:5509071
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
G
Ank3
ankyrin 3
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNS:SNPs:multiple:(human)
CTD RGD
PMID:18711365 PMID:21926974 PMID:31043756 PMID:33729739
RGD:153344594
NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
ISO ISS
MouseDO RGD
PMID:9646882
RGD:1358437
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825
G
Avpr1b
arginine vasopressin receptor 1B
ISO
DNA:SNP: :rs28536160 (human)
RGD
PMID:24012103
RGD:14700651
NCBI chr13:45,598,116...45,611,680
Ensembl chr13:45,598,763...45,611,277
G
Bdnf
brain-derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030 PMID:19018715 PMID:15118671
RGD:1331525
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
G
Bhlhe40
basic helix-loop-helix family, member e40
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25395965
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
G
Bmal1
basic helix-loop-helix ARNT like 1
sexual_dimorphism
ISO
associated with Alcohol-related disorders;DNA:SNP::(rs11600996) (Human)
RGD
PMID:30121446
RGD:405866353
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739
G
Brd1
bromodomain containing 1
susceptibility
ISO
DNA,SNP,haplotype:3'UTR:
RGD
PMID:16924267
RGD:9586096
NCBI chr 7:121,653,859...121,701,700
Ensembl chr 7:121,653,859...121,701,700
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18711365 PMID:21926972 PMID:21926974 PMID:31043756
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28194001
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
ISS
MouseDO
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504
G
Ccl2
C-C motif chemokine ligand 2
ISO
RGD
PMID:15034225
RGD:1358456
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
G
Cd47
Cd47 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272
G
Cdc42
cell division cycle 42
ISO
RGD
PMID:18391128
RGD:5688274
NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627
G
Chrm2
cholinergic receptor, muscarinic 2
ISO
DNA:SNP: :rs324650 (human) protein:decreased expression:cerebral cortex
RGD
PMID:20351719 PMID:19103464
RGD:5509579 , RGD:5509584
NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464
G
Chrnb3
cholinergic receptor nicotinic beta 3 subunit
susceptibility
ISO
DNA:SNPs: : rs4952,rs4953 (human)
RGD
PMID:21191315
RGD:405849396
NCBI chr16:71,411,847...71,454,225
Ensembl chr16:71,417,039...71,454,225
G
Clock
clock circadian regulator
ISS
MouseDO
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872
G
Comt
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism DNA:promoter:Hypomethylation
CTD RGD
PMID:11772685 PMID:16984965
RGD:401940146
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533
G
Cplx1
complexin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030
NCBI chr14:1,329,073...1,360,781
Ensembl chr14:1,329,032...1,360,769
G
Cplx2
complexin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030
NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,228,449...10,297,467
G
Cs
citrate synthase
treatment
IEP
protein decreased expression:prefrontal cortex protein decreased expression:brain
RGD
PMID:20372980 PMID:24359811 PMID:17367908
RGD:329337348 , RGD:329337349 , RGD:329337351
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
G
Ddc
dopa decarboxylase
ISO
DNA:deletions:5' utr, intron:g.-601delG, g.722_725delGAGA (human)
RGD
PMID:12555230
RGD:1358586
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
G
Disc1
DISC1 scaffold protein
susceptibility
ISO
DNA;SNPs: :rs2738864,rs16841582 (human) DNA:SNPs: :multiple DNA:SNPs: :rs1538979, rs821577, rs821633 (human)
RGD
PMID:21222298 PMID:15386212 PMID:18317464
RGD:5509829 , RGD:5509833 , RGD:5509836
NCBI chr19:69,911,548...70,120,970
Ensembl chr19:69,911,976...70,120,970
G
Dixdc1
DIX domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27752079
NCBI chr 8:59,904,218...59,977,595
Ensembl chr 8:59,904,218...59,978,447
G
Drd1
dopamine receptor D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19153942
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166
G
Drd5
dopamine receptor D5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030
NCBI chr14:76,700,244...76,703,344
Ensembl chr14:76,700,241...76,703,466
G
Erbb4
erb-b2 receptor tyrosine kinase 4
IEP
RGD
PMID:34189720
RGD:405650687
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772
G
Fads2
fatty acid desaturase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066
G
Fstl5
follistatin-like 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 2:160,857,989...161,526,589
Ensembl chr 2:163,156,576...163,825,140
G
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha 3
ISO
DNA:repeat:intron:IVS8CA (human)
RGD
PMID:11840313
RGD:1358391
NCBI chr X:155,301,979...155,543,870
Ensembl chr X:155,303,928...155,543,863
G
Gabra5
gamma-aminobutyric acid type A receptor subunit alpha 5
ISO
RGD
PMID:9514592
RGD:1358630
NCBI chr 1:117,404,446...117,517,424
Ensembl chr 1:117,404,494...117,516,635
G
Gad1
glutamate decarboxylase 1
ISO
protein:decreased expression:prefrontal cortex layers 2-5 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15560956 PMID:18534564
RGD:6480428
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
G
Gad2
glutamate decarboxylase 2
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15560956 PMID:34189720
RGD:405650687
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089
G
Gch1
GTP cyclohydrolase 1
ISO
DNA:polymorphism
RGD
PMID:15909293
RGD:1601281
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18332879
NCBI chr20:53,717,564...54,415,283
Ensembl chr20:53,716,090...54,415,202
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
ISO
DNA:repeat:promoter:(GT)18-33 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31043756 PMID:12809987
RGD:1358644
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
ISO
RGD
PMID:16549338
RGD:1642201
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
G
Grk3
G protein-coupled receptor kinase 3
ISO
mRNA, protein:decreased expression:frontal cortex (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12808434 PMID:19400979
RGD:5685029
NCBI chr12:49,285,228...49,395,803
Ensembl chr12:49,285,263...49,395,802
G
Grn
granulin precursor
ISO
protein:decreased expression:plasma
RGD
PMID:24581833
RGD:10401641
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936
G
Gsk3a
glycogen synthase kinase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20357757
NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593
G
Gsk3b
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20357757 PMID:17357145 PMID:16397405
RGD:1641929 , RGD:1641931
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
G
Hdac5
histone deacetylase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244
G
Htr2a
5-hydroxytryptamine receptor 2A
IEA ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030 PMID:15118671
RGD:1331525
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
G
Htr2c
5-hydroxytryptamine receptor 2C
ISO
DNA:missense mutation:cds:p.C23S (human)
RGD
PMID:8823764
RGD:1358737
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
G
Impa2
inositol monophosphatase 2
susceptibility
ISO
DNA:SNPs:promoter:-461C>T, -207T>C(human)
RGD
PMID:9322233 PMID:14699425 PMID:11673796
RGD:6480265 , RGD:6480267 , RGD:6480269
NCBI chr18:63,104,113...63,135,232
Ensembl chr18:63,104,083...63,137,543
G
Ins2
insulin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:5506046
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
G
Itih1
inter-alpha trypsin inhibitor, heavy chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr16:6,128,696...6,142,813
Ensembl chr16:6,128,698...6,142,853
G
Kat6b
lysine acetyltransferase 6B
ISO
DNA:mutations:multiple (human)
RGD
PMID:24444492
RGD:9588521
NCBI chr15:2,688,535...2,861,443
Ensembl chr15:2,688,811...2,844,343
G
L1cam
L1 cell adhesion molecule
ISO
associated with Depressive Disorder; mRNA:increased expression:blood (human)
RGD
PMID:18430502
RGD:6483084
NCBI chr X:156,748,597...156,775,116
Ensembl chr X:156,748,597...156,775,077
G
Lman2l
lectin, mannose-binding 2-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 9:38,661,709...38,685,244
Ensembl chr 9:46,157,596...46,181,207
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
DNA:haplotype: :
RGD
PMID:24856568
RGD:12910826
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
G
Mrps33
mitochondrial ribosomal protein S33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 4:69,563,501...69,572,317
Ensembl chr 4:69,563,503...69,572,177
G
Mt-nd1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
ISO
DNA:missense mutation:cds:m.3644T>C (human)
RGD
PMID:15533721
RGD:5490261
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,729...3,685
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17074966
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
G
Ncam1
neural cell adhesion molecule 1
ISO
DNA:snps:introns:IVS6+32T>C, IVS7+11G>C, IVS12+21C>A (human)
RGD
PMID:15050861
RGD:1358750
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971
G
Ncan
neurocan
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr16:19,335,907...19,362,371
Ensembl chr16:19,335,907...19,362,371
G
Ndufs7
NADH:ubiquinone oxidoreductase core subunit S7
ISO
protein:decreased expression:prefrontal cortex (human)
RGD
PMID:20368511
RGD:6484696
NCBI chr 7:10,103,226...10,110,862
Ensembl chr 7:10,103,227...10,110,691
G
Ndufv2
NADH:ubiquinone oxidoreductase core subunit V2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19135101
NCBI chr 9:113,137,305...113,157,571
Ensembl chr 9:113,137,306...113,157,520
G
Ngf
nerve growth factor
sexual_dimorphism
ISO
DNA:SNPs,haplotypes: :multiple
RGD
PMID:21294249
RGD:401965386
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
G
Nrg1
neuregulin 1
ISO IEP
DNA:SNP:enhancer: (rs35753505)
RGD
PMID:18585932 PMID:34189720
RGD:39131291 , RGD:405650687
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
G
Ntng1
netrin G1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17507910
NCBI chr 2:200,151,979...200,515,031
Ensembl chr 2:200,151,979...200,515,031
G
Ntng2
netrin G2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17507910
NCBI chr 3:32,889,856...32,949,032
Ensembl chr 3:32,890,575...32,943,821
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
ISO
protein:decreased expression:cerebellum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19018715 PMID:21612826
RGD:5684549
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628
G
Pacs1
phosphofurin acidic cluster sorting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 1:211,866,872...211,998,828
Ensembl chr 1:211,866,874...211,998,828
G
Pc
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:211,228,731...211,329,940
G
Pde4b
phosphodiesterase 4B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18394866
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267
G
Per3
period circadian regulator 3
sexual_dimorphism
ISO
associated with Alcohol-Related Disorders; DNA:SNP::(rs228642) (Human)
RGD
PMID:30121446
RGD:405866353
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999
G
Plekho1
pleckstrin homology domain containing O1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 2:186,233,435...186,242,114
Ensembl chr 2:186,233,452...186,241,354
G
Polg
DNA polymerase gamma, catalytic subunit
ISS
MouseDO
NCBI chr 1:142,792,119...142,808,933
Ensembl chr 1:142,792,119...142,808,838
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2843795 PMID:9664777
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173
G
Pou3f2
POU class 3 homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 5:40,874,631...40,880,539
Ensembl chr 5:40,874,601...40,881,010
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
ISO
DNA, mRNA:SNPs, haplotype, splice variant:multiple
RGD
PMID:23295814
RGD:13515076
NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,844,036...83,853,063
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
mRNA, protein:decreased expression:prefrontal cortex
RGD
PMID:20038946
RGD:5688160
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
mRNA, protein:increased expression:prefrontal cortex
RGD
PMID:20038946
RGD:5688160
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Pvalb
parvalbumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030
NCBI chr 7:111,653,820...111,668,469
Ensembl chr 7:111,653,111...111,668,446
G
Rap1gap
Rap1 GTPase-activating protein
ISO
mRNA, protein:increased expression:dorsolateral prefrontal cortex (human)
RGD
PMID:16687443
RGD:5490162
NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:155,157,558...155,222,622
G
Reln
reelin
ISO
protein:decreased expression:hippocampus (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11126396 PMID:14708030 PMID:15560956 PMID:11126396
RGD:2324681
NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162
G
Rims1
regulating synaptic membrane exocytosis 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 9:32,193,352...32,692,998
Ensembl chr 9:32,193,352...32,692,772
G
Rps6ka2
ribosomal protein S6 kinase A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 1:55,178,988...55,454,271
Ensembl chr 1:55,179,319...55,454,338
G
RT1-Da
RT1 class II, locus Da
ISO
RGD
PMID:16687443
RGD:5490162
NCBI chr20:4,515,393...4,520,387
Ensembl chr20:4,513,908...4,520,383
G
S100b
S100 calcium binding protein B
IEP ISO
protein:increased expression:cerebrospinal fluid CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15581912 PMID:16476148 PMID:15581912
RGD:5508853
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
G
Scn2a
sodium voltage-gated channel alpha subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 3:70,710,862...70,845,569
Ensembl chr 3:70,710,954...70,845,279
G
Serpina1
serpin family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17659342
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703
G
Shank2
SH3 and multiple ankyrin repeat domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 1:208,575,144...209,020,300
Ensembl chr 1:208,598,772...209,018,736
G
Slc18a1
solute carrier family 18 member A1
ISO
DNA:SNPs:5' utr, cds:g.-584A>G (rs988713), p.T136I (rs1390938) (human)
RGD
PMID:16936705
RGD:5131197
NCBI chr16:25,408,485...25,453,786
Ensembl chr16:25,420,243...25,453,786
G
Slc5a3
solute carrier family 5 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16420717
NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157
G
Slc6a4
solute carrier family 6 member 4
ISO
CTD Direct Evidence: marker/mechanism DNA:repeats:promoter:
CTD RGD
PMID:11772685 PMID:16395126 PMID:10484962
RGD:36947381
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056
G
Snap25
synaptosome associated protein 25
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14708030
NCBI chr 3:144,494,579...144,576,449
Ensembl chr 3:144,494,595...144,576,448
G
Snca
synuclein alpha
ISO
RGD
PMID:19198857
RGD:6478716
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315
G
Sp4
Sp4 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19401786
NCBI chr 6:145,330,416...145,395,750
Ensembl chr 6:145,330,416...145,395,146
G
Srpk2
SRSF protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 4:12,356,983...12,548,345
Ensembl chr 4:12,357,053...12,548,342
G
Srsf3
serine and arginine rich splicing factor 3
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:18281098
RGD:11039413
NCBI chr20:7,093,529...7,103,517
Ensembl chr20:7,093,565...7,103,516
G
Ssbp2
single-stranded DNA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 2:24,385,494...24,673,768
Ensembl chr 2:24,385,687...24,673,768
G
Sstr5
somatostatin receptor 5
ISO
DNA:SNP, missense mutations, haplotype: :573G>A, p.L48M, p.P335L (human)
RGD
PMID:12192619
RGD:1358589
NCBI chr10:15,010,209...15,017,469
Ensembl chr10:15,011,391...15,017,469
G
Stard9
StAR-related lipid transfer domain containing 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 3:128,034,866...128,150,493
Ensembl chr 3:128,034,908...128,127,402
G
Stk4
serine/threonine kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 3:173,165,238...173,247,135
Ensembl chr 3:173,165,083...173,247,134
G
Syne1
spectrin repeat containing nuclear envelope protein 1
susceptibility
ISO
DNA:SNPs:promoter,intron:
RGD
PMID:28178086
RGD:13209005
NCBI chr 1:43,917,640...44,388,802
Ensembl chr 1:43,895,994...44,388,721
G
Tac1
tachykinin, precursor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15845098
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546
G
Tacr1
tachykinin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19204064
NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:116,478,617...116,647,492
G
Tenm4
teneurin transmembrane protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21926972
NCBI chr 1:157,699,611...160,674,549
Ensembl chr 1:159,974,017...160,674,549
G
Thsd7a
thrombospondin type 1 domain containing 7A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 4:41,427,276...41,865,524
Ensembl chr 4:41,426,275...41,865,723
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
protein:increased expression:plasma
RGD
PMID:20861651
RGD:7205488
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
G
Tph2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:frontal association cortex ClinVar Annotator: match by term: Bipolar affective disorder, susceptibility to
ClinVar RGD
PMID:17905754 PMID:18347598 PMID:19319927 PMID:25741868 PMID:16240163
RGD:5686358
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:52,571,911...52,675,639
G
Trank1
tetratricopeptide repeat and ankyrin repeat containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 8:120,153,381...120,233,879
Ensembl chr 8:120,154,362...120,234,087
G
Trpc3
transient receptor potential cation channel, subfamily C, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23602965
NCBI chr 2:121,409,436...121,487,095
Ensembl chr 2:121,409,436...121,475,823
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23602965
NCBI chr20:10,703,190...10,752,795
Ensembl chr20:10,704,482...10,752,802
G
Tshb
thyroid stimulating hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6455462
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984
G
Vwf
von Willebrand factor
ISO
protein:increased expression:plasma
RGD
PMID:19839997
RGD:7207027
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757
G
Zcchc2
zinc finger CCHC-type containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr13:22,621,275...22,708,232
Ensembl chr13:22,634,171...22,708,464
G
Zfp592
zinc finger protein 592
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31043756
NCBI chr 1:144,355,227...144,411,686
Ensembl chr 1:144,361,654...144,411,684
G
Xbp1
X-box binding protein 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Major affective disorder 7
OMIM CTD ClinVar
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all